BFM
SNY icon

Boothbay Fund Management’s Sanofi SNY Stock Holding History

Boothbay Fund Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-69,600
Closed -$2.65M – 2415
2022
Q3 		$2.65M Buy
+69,600
New +$3.1M 0.07% 439

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Boothbay Fund Management's SNY Position: Q2 2026 in Review

Boothbay Fund Management increased its Sanofi (SNY) stake by 73% in Q2 2026, buying an estimated $886K and bringing the position to 46,970 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #718.

Boothbay Fund Management first reported a position in SNY in Q1 2019 and has held it in 17 quarters since. The position peaked at $19M in Q4 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Boothbay Fund Management held 46,970 shares of Sanofi worth $2M as of Q2 2026.
  • Boothbay Fund Management bought 19,838 Sanofi shares in Q2 2026, an estimated $886K.
  • Sanofi made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #718 holding.
  • Boothbay Fund Management first reported a position in Sanofi in Q1 2019 and has held it in 17 quarters since.
  • Boothbay Fund Management's Sanofi position peaked at $19M in Q4 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.